Thrombosis
From the Journals
Mixed results for cardiologists in stroke thrombectomy
Specialized training and collaboration between specialties, experts say, are essential for interventional cardiologists to achieve results similar...
Conference Coverage
New stroke risk score developed for COVID patients
The user-friendly score represents a step forward but also points to the need to better risk-stratify patients for this complex, expensive, and...
Feature
Novel drug targets raised Lp(a): topline results released
Significant reductions in lipoprotein(a) were sustained out to 150 days in patients without cardiovascular disease in top-line phase 1 results...
From the Journals
Merits of short DAPT, de-escalation in ACS challenge guidelines
Results from the meta-analysis should put the alternative strategies on par with each other or even dethrone standard DAPT in current guidelines,...
From the Journals
‘Substantial’ CVD risks, burden up to a year after COVID-19
Governments and health systems need to be prepared to deal with the likely significant contribution of the pandemic to a rising burden of...
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...
From the Journals
Ischemic stroke rates higher in young women than young men
Young women may be at a higher risk of ischemic stroke than young men, representing a “significant departure from our current scientific...
Feature
CVS Caremark formulary change freezes out apixaban
The decision doesn’t affect patients on a Medicare or Medicaid plan but hits those taking the popular anticoagulant who have select commercial...
Feature
A high-risk medical device didn’t meet federal standards. The government paid millions for more
For years after federal inspectors found serious problems with the HeartWare heart pump, agencies like the Department of Veterans Affairs and...
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.